KOPS - Das Institutionelle Repositorium der Universität Konstanz

Current approaches and future role of high content imaging in safety sciences and drug discovery

Current approaches and future role of high content imaging in safety sciences and drug discovery

Zitieren

Dateien zu dieser Ressource

Prüfsumme: MD5:e1a8a1ef3d4f926fe436cd1d3ca49391

VAN VLIET, Erwin, Mardas DANESHIAN, Mario BEILMANN, Anthony DAVIES, Eugenio FAVA, Roland FLECK, Yvon JULE, Manfred KANSY, Stefan KUSTERMANN, Peter MACKO, William MUNDY, Adrian ROTH, Christoph SACHSE, Imran SHAH, Marianne UTENG, Bob VAN DE WATER, Thomas HARTUNG, Marcel LEIST, 2014. Current approaches and future role of high content imaging in safety sciences and drug discovery. In: Alternatives to Animal Experimentation : ALTEX. 31(4), pp. 479-493. ISSN 1868-596X. eISSN 1868-8551

@article{van Vliet2014Curre-30054, title={Current approaches and future role of high content imaging in safety sciences and drug discovery}, year={2014}, doi={10.14573/altex.1405271}, number={4}, volume={31}, issn={1868-596X}, journal={Alternatives to Animal Experimentation : ALTEX}, pages={479--493}, author={van Vliet, Erwin and Daneshian, Mardas and Beilmann, Mario and Davies, Anthony and Fava, Eugenio and Fleck, Roland and Jule, Yvon and Kansy, Manfred and Kustermann, Stefan and Macko, Peter and Mundy, William and Roth, Adrian and Sachse, Christoph and Shah, Imran and Uteng, Marianne and van de Water, Bob and Hartung, Thomas and Leist, Marcel} }

<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/30054"> <dc:creator>Kansy, Manfred</dc:creator> <dc:creator>Beilmann, Mario</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-02-25T11:10:59Z</dc:date> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/30054"/> <dc:creator>Sachse, Christoph</dc:creator> <dc:creator>Kustermann, Stefan</dc:creator> <dc:creator>Daneshian, Mardas</dc:creator> <dc:contributor>Beilmann, Mario</dc:contributor> <dc:contributor>Fleck, Roland</dc:contributor> <dc:creator>Mundy, William</dc:creator> <dc:creator>Jule, Yvon</dc:creator> <dc:creator>Leist, Marcel</dc:creator> <dc:contributor>Leist, Marcel</dc:contributor> <dc:contributor>Daneshian, Mardas</dc:contributor> <dc:contributor>Sachse, Christoph</dc:contributor> <dc:creator>Uteng, Marianne</dc:creator> <dc:contributor>van de Water, Bob</dc:contributor> <dc:contributor>van Vliet, Erwin</dc:contributor> <dc:creator>Shah, Imran</dc:creator> <dc:contributor>Kansy, Manfred</dc:contributor> <dc:contributor>Macko, Peter</dc:contributor> <dc:language>eng</dc:language> <dc:creator>van de Water, Bob</dc:creator> <dc:contributor>Hartung, Thomas</dc:contributor> <dc:contributor>Shah, Imran</dc:contributor> <dc:creator>Fava, Eugenio</dc:creator> <dcterms:issued>2014</dcterms:issued> <dc:creator>Macko, Peter</dc:creator> <dc:contributor>Davies, Anthony</dc:contributor> <dcterms:title>Current approaches and future role of high content imaging in safety sciences and drug discovery</dcterms:title> <dc:creator>Davies, Anthony</dc:creator> <dc:creator>Hartung, Thomas</dc:creator> <dc:contributor>Kustermann, Stefan</dc:contributor> <dc:contributor>Fava, Eugenio</dc:contributor> <dcterms:abstract xml:lang="eng">High content imaging combines automated microscopy with image analysis approaches to simultaneously quantify multiple phenotypic and/or functional parameters in biological systems. The technology has become an important tool in the fields of safety sciences and drug discovery, because it can be used for mode-of-action identification, determination of hazard potency and the discovery of toxicity targets and biomarkers. In contrast to conventional biochemical endpoints, high content imaging provides insight into the spatial distribution and dynamics of responses in biological systems. This allows the identification of signaling pathways underlying cell defense, adaptation, toxicity and death. Therefore, high content imaging is considered a promising technology to address the challenges for the Toxicity testing in the 21st century approach. Currently, high content imaging technologies are frequently applied in academia for mechanistic toxicity studies and in pharmaceutical industry for the ranking and selection of lead drug compounds or to identify/confirm mechanisms underlying effects observed in vivo. A recent workshop gathered scientists working on high content imaging in academia, pharmaceutical industry and regulatory bodies with the objective to compile the state-of-the-art of the technology in the different institutions. Together they defined technical and methodological gaps, proposed quality control measures and performance standards, highlighted cell sources and new readouts and discussed future requirements for regulatory implementation. This review summarizes the discussion, proposed solutions and recommendations of the specialists contributing to the workshop.</dcterms:abstract> <dc:contributor>Jule, Yvon</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2015-02-25T11:10:59Z</dcterms:available> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <dc:contributor>Roth, Adrian</dc:contributor> <dc:creator>Roth, Adrian</dc:creator> <dc:creator>Fleck, Roland</dc:creator> <dc:contributor>Uteng, Marianne</dc:contributor> <dc:creator>van Vliet, Erwin</dc:creator> <dc:contributor>Mundy, William</dc:contributor> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 25.02.2015 (Informationen über die Zugriffsstatistik)

Vliet_0-264743.pdf 240

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto